Business
REMSleep Holdings Announces Full Commercial Launch of DeltaWave(TM)
REMSleep Holdings Announces Full Commercial Launch of DeltaWave(TM).
About this update from Remsleep Holdings, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n REMSleep Holdings Announces Full Commercial Launch of DeltaWave(TM)\r\n \r\n \r\n\r\n\r\nREMSleep Holdings Announces Full Commercial Launch of DeltaWave(TM)\r\n\r\n\r\n\r\n\r\n\r\nNasal Pillow System All Configurations and Accessories Now Available to DME Providers, Physicians, and Patients Nationwide - The Last Piece of a Three-Year Build Has Clicked Into Place\r\nBLACKSHEAR, GA - February 24, 2026 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTCQB: RMSL), developer of the FDA-cleared DeltaWave(TM) nasal pillow system, today announced the full commercial launch of the DeltaWave product portfolio across all U.S. distribution channels, including durable medical equipment (DME) companies, and institutional sales.\r\nThis isn't a soft launch or a limited rollout. It's the real thing.\r\nWith expanded FDA 510(k) clearance secured on January 15 and Medicare PDAC coding approved for every product configuration on January 21, the final regulatory prerequisites for nationwide distribution are now in place. REMSleep is fully open for business.\r\nHow We Got Here\r\nShareholders who've followed along over the past several months know this moment didn't happen overnight. The company has been methodically building the foundation required to support a commercial launch that could actually scale:\r\n\r\n December 2025: Enterprise ERP systems activated, nationwide independent sales force deployed across 48 states, product inventory received\r\n December 2025: Zero-return, repeat-order results validated from early adopting DME partners during soft launch\r\n January 7, 2026: Expanded 510(k) clearance (K253939) received - DeltaWave's indicated use broadened to BiPAP, institutional settings, hospitals, long-term care, and sleep labs\r\n January 21, 2026: Full PDAC/HCPCS coding approval received for every DeltaWave configuration, enabling DME providers to bill Medicare and private insurers\r\n February 2026: Full commercial launch, all channels, all configurations\r\n \r\n That's the arc. Infrastructure first. Clearances second. Launch third.\r\nWhat's in the Portfolio\r\nThe DeltaWave Nasal Pillow System is built around a patented Direct Airflow Technology - a design that reduces the pressure and airflow sensation patients feel at the nasal interface. It's a unique engineering design with real clinical impact: patients who feel le...